Dimensional Fund Advisors’s PDS Biotechnology PDSB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-18,382
Closed -$18.6K 3299
2025
Q3
$18.6K Hold
18,382
﹤0.01% 3268
2025
Q2
$24.4K Hold
18,382
﹤0.01% 3264
2025
Q1
$21.9K Sell
18,382
-8
-0% -$11 ﹤0.01% 3298
2024
Q4
$30K Sell
18,390
-6,908
-27% -$18.3K ﹤0.01% 3315
2024
Q3
$96.6K Sell
25,298
-14,335
-36% -$47.8K ﹤0.01% 3242
2024
Q2
$116K Sell
39,633
-8
-0% -$26 ﹤0.01% 3232
2024
Q1
$157K Sell
39,641
-2,523
-6% -$13K ﹤0.01% 3213
2023
Q4
$210K Sell
42,164
-1,978
-4% -$9.83K ﹤0.01% 3188
2023
Q3
$223K Sell
44,142
-10,291
-19% -$56.4K ﹤0.01% 3197
2023
Q2
$274K Sell
54,433
-287
-0.5% -$1.88K ﹤0.01% 3181
2023
Q1
$337K Sell
54,720
-3,550
-6% -$29K ﹤0.01% 3101
2022
Q4
$768 Buy
58,270
+27,889
+92% +$197K ﹤0.01% 2964
2022
Q3
$90K Sell
30,381
-789
-3% -$3.35K ﹤0.01% 3352
2022
Q2
$114K Sell
31,170
-38,458
-55% -$183K ﹤0.01% 3317
2022
Q1
$431K Buy
69,628
+34,797
+100% +$216K ﹤0.01% 3184
2021
Q4
$282K Buy
+34,831
New +$375K ﹤0.01% 3285
2020
Q2
Sell
-12,991
Closed -$9K 3356
2020
Q1
$9K Sell
12,991
-1,525
-11% -$2.64K ﹤0.01% 3372
2019
Q4
$38K Hold
14,516
﹤0.01% 3356
2019
Q3
$48K Hold
14,516
﹤0.01% 3385
2019
Q2
$87K Buy
+14,516
New +$94.9K ﹤0.01% 3405

Other funds holding PDSB

Dimensional Fund Advisors's PDSB Position: Q4 2025 in Review

Dimensional Fund Advisors sold out of PDS Biotechnology (PDSB) in Q4 2025, closing a stake of 18,382 shares — an estimated $18.6K sold.

Dimensional Fund Advisors first reported a position in PDSB in Q2 2019 and held it in 20 quarters. The position peaked at $431K in Q1 2022. 44 funds tracked by Wall St. Rank hold PDSB as of Q4 2025.

  • Dimensional Fund Advisors reported no remaining PDS Biotechnology position as of Q4 2025 after selling out during the quarter.
  • Dimensional Fund Advisors sold 18,382 PDS Biotechnology shares in Q4 2025, an estimated $18.6K.
  • Dimensional Fund Advisors first reported a position in PDS Biotechnology in Q2 2019 and held it in 20 quarters.
  • Dimensional Fund Advisors's PDS Biotechnology position peaked at $431K in Q1 2022.
  • 44 funds tracked by Wall St. Rank held PDS Biotechnology as of Q4 2025.

Based on Dimensional Fund Advisors's 13F filing for Q4 2025, filed 12 Feb 2026.